Kalamazoo, MI, United States of America

Leroy E Johnson

This inventor holds 1 USPTO granted patent. Top assignee: The Upjohn Co.. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leroy E Johnson. Retrieved from https://idiyas.com/inventor/leroy-e-johnson-kfs76qh0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leroy E. Johnson: Innovator in Antibiotic Development

Introduction

Leroy E. Johnson is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of antibiotic research, particularly through his innovative fermentation processes. His work has led to the development of novel antibiotics that hold promise for medical applications.

Latest Patents

Leroy E. Johnson holds a patent for "Paulomycin A and B and preparation thereof." This patent discloses and claims an improved fermentation process for preparing the known antibiotic U-43,120, referred to as paulomycin. Additionally, the patent introduces the novel antibiotics paulomycin A and paulomycin B, showcasing his innovative approach to antibiotic development.

Career Highlights

Throughout his career, Johnson has been associated with The Upjohn Company, where he has focused on antibiotic research and development. His work has contributed to advancements in the pharmaceutical industry, particularly in the area of antibiotic production.

Collaborations

Johnson has collaborated with notable colleagues, including Alexander D. Argoudelis and Vincent P. Marshall. These collaborations have further enhanced his research and development efforts in the field of antibiotics.

Conclusion

Leroy E. Johnson's contributions to antibiotic research through his innovative fermentation processes and the development of novel antibiotics underscore his importance in the field. His work continues to influence advancements in medical science and antibiotic production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…